Kesumayadi I, Kambe A, Amisaki H, Hosoya T, et al. Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis. J Neurooncol 2025 Sep 9. doi: 10.1007/s11060-025-05209.
PMID: 40924324